[July 15, 2014]

Research and Markets: Russia Clinical Development Country Profile

Research and Markets (http://www.researchandmarkets.com/research/xqhwkm/russia_clinical) has announced the addition of the "Russia: Clinical Development Country Profile" report to their offering.

The report provides insight into the clinical development environment, sponsor and service provider activities, and population health status for Russia. With this report, sponsors and service providers can make informed strategic development decisions by understanding the benefits and drawbacks to conducting trials in Russia.

How You Can Use This Report:

• Understand how sponsors and CROs view Rusia as a site for clinical trials and where the country fits within their clinical development strategy
• Uncover logistical details for conducting Russian trials
• Illustrate the benefits and drawbacks of conducting trials in Russia
• Target (News - Alert) specific indications by learning how Russia compares to other countries on a variety health statistics
• Set realistic expectations for trial operations and timing by reviewing historic, country specific trial metrics

• On-the-ground insights from several industry KOLs from top pharma companies and country heads from a multinational CRO
• How its economy and national policies make Russia an attractive country for clinical trial activity, and why regulatory uncertainty and process challenges remain
• Health statistics for Russia, including life expectancy, cancer and AIDS incidence rates, alcohol and tobacco consumption, and more
• Capabilities of domestic service providers and contact details for domestic pharmaceutical companies
• Regulatory environment/ considerations and how they compare to EU standards

Key Topics Covered:

1. Introduction

2. Russia Health Statistics

3. Clinical Trial Overview

4. Clinical Service Provider Capabilities

For more information visit http://www.researchandmarkets.com/research/xqhwkm/russia_clinical

[ Back To TMCnet.com's Homepage ]